GreenLight Biosciences Stock

greenlightbiosciences.comHealthcareFounded: 2008Funding to Date: $141.55MM

GreenLight Biosciences is a biotech company leveraging RNA to tackle some of humanity's greatest challenges, including pandemics, rare diseases, biodiversity and climate change.

Register for Details

For more details on financing and valuation for GreenLight Biosciences, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for GreenLight Biosciences.

Register Today

Team

Management Team

Carole Cobb
Chief Operating Officer
Andrey Zarur Ph.D
Co-Founder, Chief Executive Officer, President & Board Member
Mick Messman
Chief Commercial Officer
Marta Ortega-Valle
Co-Founder & Senior Vice President, Corporate Development

Board Members

Colin Steen
Syngenta Ventures
Eric O'Brien
Fall Line Capital
James Swartz Ph.D
Martha Schlicher
Neil Renninger Ph.D
Khosla Ventures
David Furneaux
Kodiak Venture Partners
David Russell Ph.D
Lewis & Clark Ventures
Gregory Lucier
Jonathan Fleming
Oxford Bioscience Partners
Andrey Zarur Ph.D
Charles Cooney Ph.D
Ganesh Kishore Ph.D
Spruce Capital Partners
Mark Cupta
Prelude Ventures
Matthew Walker

Other companies like GreenLight Biosciences in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$885.01MM

News

GreenLight Biosciences, a bio-performance company developing RNA-based solutions for agriculture and pharmaceutical applications, raised $50m in funding